We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mallinckrodt Loses Lawsuit Against FDA Over ADHD Drug
Mallinckrodt Loses Lawsuit Against FDA Over ADHD Drug
A U.S. district court in Maryland has let stand the FDA’s November 2014 decision to revoke Mallinckrodt’s equivalence rating for its generic version of Janssen’s ADHD drug Concerta.